References
- Dannon PN, Lowengrub K, Gonopolski Y, Musin E, Kotler M. Topiramate versus fluvoxamine in the treatment of pathological gambling: a randomized, blind-rater comparison study. Clin Neuropharmacol 2005; 28: 6–10
- McElroy SL, Pope HGJr, Keck PEJr, Hudson JI, Phillips KA, Strakowski SM. Are impulse-control disorders related to bipolar disorder?. Compr Psychiatry 1996; 37: 229–240
- Hollander E, Pallanti S, Allen A, Sood E, Baldini Rossi N. Does sustained-release lithium reduce impulsive gambling and affective instability versus placebo in pathological gamblers with bipolar spectrum disorders?. Am J Psychiatry 2005; 162: 137–145
- McElroy SL, Arnold LM, Shapira NA, et al. Topiramate in the treatment of binge eating disorder associated with obesity: a randomized, placebo-controlled trial. Am J Psychiatry 2003; 160: 255–261
- Volkow ND, Fowler JS. Addiction, a disease of compulsion and drive: involvement of the orbitofrontal cortex. Cereb Cortex 2000; 10: 318–325
- Schweitzer R, Greenslade J, Kagee A. Coping and resilience in refugees from the Sudan: a narrative account. Aust N Z J Psychiatry 2007; 41: 282–288
- Lakka HM, Laaksonen DE, Lakka TA, et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002; 288: 2709–2716
- Grundy SM, Cleeman JI, Merz CN, et al. NHLB Institute, ACCF, AHA. Implications of recent clinical trials for National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 2004; 110: 227–239
- IDF. The IDF consensus worldwide definition of metabolic syndrome. Brussels: International Diabetes Federation, 2005. Available at, , www.idf.org.
- Misra A, Wasir JS, Vikram NK. Waist circumference criteria for diagnosis of abdominal obesity not applicable uniformly to all populations and ethnic groups. Nutrition 2005; 21: 969–976
- De Hert MA, van Winkel R, Van Eyck D, et al. Prevalence of metabolic syndrome in patients with schizophrenia treated with antipsychotic medication. Schizophr Res 2006; 83: 87–93